Literature DB >> 27589528

EEG Markers of Dementia with Lewy Bodies: A Multicenter Cohort Study.

Laura Bonanni1, Raffaella Franciotti1, Flavio Nobili2, Milica G Kramberger3, John-Paul Taylor4, Sara Garcia-Ptacek5, N Walter Falasca6, Francesco Famá2, Ruth Cromarty4, Marco Onofrj1, Dag Aarsland7.   

Abstract

Quantitative EEG (QEEG) has demonstrated good discriminative capacity for dementia with Lewy bodies (DLB) diagnosis as compared to Alzheimer's disease (AD) with a predictive value of 100% in a single cohort study. EEG in DLB was characterized by a dominant frequency (DF) in pre-alpha (5.5-7.5 Hz), theta, or delta bands and DF variability (DFV) >1.2 Hz, frequency prevalence (FP) pre-alpha in >40% and FP alpha in <32% of the epochs. To validate the aforementioned QEEG findings in independent cohorts of clinically diagnosed DLB versus AD patients, we analyzed EEG traces of 79 DLB and 133 AD patients (MMSE >20) collected from four European Centers. EEG traces from 19 scalp derivations were acquired as at least 10 min continuous signals and epoched in off-setting as series of 2-second-long epochs, subsequently processed by Fast Fourier Transform (frequency resolution 0.5 Hz). DLB patients showed EEG specific abnormalities in posterior derivations characterized by DF <8 Hz FP pre-alpha >50%, FP alpha <25%. DFV was >0.5 Hz. AD patients displayed stable alpha DF, DFV <0.5 Hz, FP pre-alpha <30%, and FP alpha >55%. DLB and AD differed for DF (p < 10-6), DFV (p < 0.05), FP pre-alpha (p < 10-12) and FP alpha (p < 10-12). Discriminant analysis detected specific cut-offs for every EEG mathematical descriptor; DF = 8, DFV = 2.2 Hz, FP pre-alpha=33%, FP alpha = 41% for posterior derivations. If at least one of the cut-off values was met, the percentage of DLB and AD patients correctly classified was 90% and 64%, respectively. The findings in this multicenter study support the validity of QEEG analysis as a tool for diagnosis in DLB patients.

Entities:  

Keywords:  Dementia with Lewy bodies; quantitative EEG

Mesh:

Year:  2016        PMID: 27589528     DOI: 10.3233/JAD-160435

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  11 in total

Review 1.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

Review 2.  Electroencephalogram in dementia with Lewy bodies: a systematic review.

Authors:  Simela Chatzikonstantinou; Jack McKenna; Eleni Karantali; Fivos Petridis; Dimitrios Kazis; Ioannis Mavroudis
Journal:  Aging Clin Exp Res       Date:  2020-05-07       Impact factor: 3.636

3.  Biomarker Use for Dementia With Lewy Body Diagnosis: Survey of US Experts.

Authors:  Melissa J Armstrong; David J Irwin; James B Leverenz; Noheli Gamez; Angela Taylor; James E Galvin
Journal:  Alzheimer Dis Assoc Disord       Date:  2021 Jan-Mar 01       Impact factor: 2.357

4.  Quantitative electroencephalography as a marker of cognitive fluctuations in dementia with Lewy bodies and an aid to differential diagnosis.

Authors:  Myrto Stylianou; Nicholas Murphy; Luis R Peraza; Sara Graziadio; Ruth Cromarty; Alison Killen; John T O' Brien; Alan J Thomas; Fiona E N LeBeau; John-Paul Taylor
Journal:  Clin Neurophysiol       Date:  2018-04-03       Impact factor: 3.708

5.  Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?

Authors:  Kurt A Jellinger; Amos D Korczyn
Journal:  BMC Med       Date:  2018-03-06       Impact factor: 8.775

6.  Quantitative EEG as a biomarker in mild cognitive impairment with Lewy bodies.

Authors:  Julia Schumacher; John-Paul Taylor; Calum A Hamilton; Michael Firbank; Ruth A Cromarty; Paul C Donaghy; Gemma Roberts; Louise Allan; Jim Lloyd; Rory Durcan; Nicola Barnett; John T O'Brien; Alan J Thomas
Journal:  Alzheimers Res Ther       Date:  2020-07-08       Impact factor: 6.982

7.  Dysfunctional brain dynamics and their origin in Lewy body dementia.

Authors:  Julia Schumacher; Luis R Peraza; Michael Firbank; Alan J Thomas; Marcus Kaiser; Peter Gallagher; John T O'Brien; Andrew M Blamire; John-Paul Taylor
Journal:  Brain       Date:  2019-06-01       Impact factor: 13.501

8.  Electroencephalographic derived network differences in Lewy body dementia compared to Alzheimer's disease patients.

Authors:  Luis R Peraza; Ruth Cromarty; Xenia Kobeleva; Michael J Firbank; Alison Killen; Sara Graziadio; Alan J Thomas; John T O'Brien; John-Paul Taylor
Journal:  Sci Rep       Date:  2018-03-15       Impact factor: 4.379

9.  EEG Characteristics of Dementia With Lewy Bodies, Alzheimer's Disease and Mixed Pathology.

Authors:  Jessica J van der Zande; Alida A Gouw; Inger van Steenoven; Philip Scheltens; Cornelis Jan Stam; Afina W Lemstra
Journal:  Front Aging Neurosci       Date:  2018-07-03       Impact factor: 5.750

Review 10.  Dementia with Lewy bodies: an update and outlook.

Authors:  Tiago Fleming Outeiro; David J Koss; Daniel Erskine; Lauren Walker; Marzena Kurzawa-Akanbi; David Burn; Paul Donaghy; Christopher Morris; John-Paul Taylor; Alan Thomas; Johannes Attems; Ian McKeith
Journal:  Mol Neurodegener       Date:  2019-01-21       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.